| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 50.786 | 57.847 | 70.113 | 73.980 | 78.656 | 50.340 | 69.764 | 89.525 | 84.737 | 71.940 |
| Total Income - EUR | 50.804 | 57.854 | 70.113 | 73.980 | 78.656 | 52.152 | 70.519 | 89.526 | 84.737 | 71.940 |
| Total Expenses - EUR | 39.960 | 29.856 | 36.232 | 37.833 | 31.350 | 30.191 | 36.591 | 40.558 | 42.069 | 40.562 |
| Gross Profit/Loss - EUR | 10.844 | 27.999 | 33.881 | 36.147 | 47.306 | 21.961 | 33.928 | 48.968 | 42.668 | 31.378 |
| Net Profit/Loss - EUR | 9.320 | 27.420 | 33.180 | 35.408 | 46.523 | 21.625 | 33.480 | 48.090 | 41.838 | 29.263 |
| Employees | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Anvima Ped - 2 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.167 | 10.383 | 7.768 | 6.279 | 4.274 | 2.911 | 3.445 | 2.828 | 2.099 | 1.039 |
| Current Assets | 28.526 | 17.597 | 26.236 | 29.728 | 43.134 | 20.667 | 31.779 | 47.325 | 41.373 | 53.792 |
| Inventories | 0 | 0 | 0 | 299 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.271 | 0 | 0 | 4.029 | 115 | 124 | 121 | 357 | 18.889 | 22.834 |
| Cash | 25.254 | 17.597 | 26.236 | 25.399 | 43.020 | 20.542 | 31.658 | 46.968 | 22.485 | 30.958 |
| Shareholders Funds | 34.598 | 27.474 | 33.232 | 35.459 | 46.574 | 21.674 | 33.529 | 48.139 | 41.886 | 29.311 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.094 | 507 | 771 | 548 | 834 | 1.903 | 1.695 | 2.014 | 1.586 | 25.520 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Anvima Ped - 2 Srl